相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Complement Inhibition: A Novel Form of Immunotherapy for Colon Cancer
Stephanie Downs-Canner et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Cancer immunotherapy: the beginning of the end of cancer?
Sofia Farkona et al.
BMC MEDICINE (2016)
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Lena M. Kranz et al.
NATURE (2016)
The Human Vaccines Project: A roadmap for cancer vaccine development
Pedro Romero et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Vaccines for established cancer: overcoming the challenges posed by immune evasion
Sjoerd H. van der Burg et al.
NATURE REVIEWS CANCER (2016)
PTX3 Is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer
Eduardo Bonavita et al.
CELL (2015)
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma
Marta Mazzocco et al.
IMMUNOLOGY (2015)
Complement 5a Enhances Hepatic Metastases of Colon Cancer via Monocyte Chemoattractant Protein-1-mediated Inflammatory Cell Infiltration
Chunmei Piao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Monitoring and Cell-Specific Deletion of C5aR1 Using a Novel Floxed GFP-C5aR1 Reporter Knock-in Mouse
Christian M. Karsten et al.
JOURNAL OF IMMUNOLOGY (2015)
A Tumor Mitochondria Vaccine Protects against Experimental Renal Cell Carcinoma
Stefano Pierini et al.
JOURNAL OF IMMUNOLOGY (2015)
Complement C5a Receptor Facilitates Cancer Metastasis by Altering T-Cell Responses in the Metastatic Niche
Surya Kumari Vadrevu et al.
CANCER RESEARCH (2014)
Tumor endothelial marker 1-specific DNA vaccination targets tumor vasculature
John G. Facciponte et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
Gregory T. Motz et al.
NATURE MEDICINE (2014)
Therapeutic vaccines for cancer: an overview of clinical trials
Ignacio Melero et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Autocrine Effects of Tumor-Derived Complement
Min Soon Cho et al.
CELL REPORTS (2014)
Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Alloantibody and Complement Promote T Cell-Mediated Cardiac Allograft Vasculopathy Through Noncanonical Nuclear Factor-κB Signaling in Endothelial Cells
Dan Jane-wit et al.
CIRCULATION (2013)
Deciphering and Reversing Tumor Immune Suppression
Greg T. Motz et al.
IMMUNITY (2013)
New analogs of the clinical complement inhibitor compstatin with subnanomolar affinity and enhanced pharmacokinetic properties
Hongchang Qu et al.
IMMUNOBIOLOGY (2013)
An Essential Role for C5aR Signaling in the Optimal Induction of a Malaria-Specific CD4+ T Cell Response by a Whole-Killed Blood-Stage Vaccine
Taiping Liu et al.
JOURNAL OF IMMUNOLOGY (2013)
Complement in Immune and Inflammatory Disorders: Therapeutic Interventions
Daniel Ricklin et al.
JOURNAL OF IMMUNOLOGY (2013)
International Union of Pharmacology. LXXXVII. Complement Peptide C5a, C4a, and C3a Receptors
Andreas Klos et al.
PHARMACOLOGICAL REVIEWS (2013)
C5aR Expression in a Novel GFP Reporter Gene Knockin Mouse: Implications for the Mechanism of Action of C5aR Signaling in T Cell Immunity
Jason Dunkelberger et al.
JOURNAL OF IMMUNOLOGY (2012)
Anaphylatoxin C5a Creates a Favorable Microenvironment for Lung Cancer Progression
Leticia Corrales et al.
JOURNAL OF IMMUNOLOGY (2012)
Genetic and Pharmacologic Inhibition of Complement Impairs Endothelial Cell Function and Ablates Ovarian Cancer Neovascularization
Selene Nunez-Cruz et al.
NEOPLASIA (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
Cyclic GMP protects endothelial progenitors from oxidative stress
Anna Maria Curatola et al.
ANGIOGENESIS (2011)
Agonist Anti-CD137 mAb Act on Tumor Endothelial Cells to Enhance Recruitment of Activated T Lymphocytes
Asis Palazon et al.
CANCER RESEARCH (2011)
Prognostic and Predictive Impact of Intra- and Peritumoral Immune Infiltrates
Wolf Herman Fridman et al.
CANCER RESEARCH (2011)
CD4+ T-Cell Help in the Tumor Milieu Is Required for Recruitment and Cytolytic Function of CD8+ T Lymphocytes
Rinke Bos et al.
CANCER RESEARCH (2010)
Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer
Rajeev K. Shrimali et al.
CANCER RESEARCH (2010)
Complement: a key system for immune surveillance and homeostasis
Daniel Ricklin et al.
NATURE IMMUNOLOGY (2010)
Endothelin B Receptor, a New Target in Cancer Immune Therapy
Lana E. Kandalaft et al.
CLINICAL CANCER RESEARCH (2009)
Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response
Gabrielle A. Rizzuto et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Deletion of both the C3a and C5a receptors fails to protect against experimental autoimmune encephalomyelitis
Theresa N. Ramos et al.
NEUROSCIENCE LETTERS (2009)
Induction of antitumor immunity in vivo following delivery of a novel HPV-16 DNA vaccine encoding an E6/E7 fusion antigen
Jian Yan et al.
VACCINE (2009)
Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis
Peter N. Lalli et al.
BLOOD (2008)
Preventive Vaccination with Telomerase Controls Tumor Growth in Genetically Engineered and Carcinogen-Induced Mouse Models of Cancer
Carmela Mennuni et al.
CANCER RESEARCH (2008)
Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells
Michael G. Strainic et al.
IMMUNITY (2008)
Tumor-specific CD4+ T cells render the tumor environment permissive for infiltration by low-avidity CD8+ T cells
S. B. Justin Wong et al.
JOURNAL OF IMMUNOLOGY (2008)
Cancer exploiting complement: a clue or an exception?
Bruce E. Loveland et al.
NATURE IMMUNOLOGY (2008)
Modulation of the antitumor immune response by complement
Maciej M. Markiewski et al.
NATURE IMMUNOLOGY (2008)
Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy
Ronald J. Buckanovich et al.
NATURE MEDICINE (2008)
A vascular endothelial growth factor receptor-2 inhibitor enhances antitumor immunity through an immune-based mechanism
Elizabeth A. Manning et al.
CLINICAL CANCER RESEARCH (2007)
Tumor vascular proteins as biomarkers in ovarian cancer
Ronald J. Buckanovich et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Nitric oxide donor-induced persistent inhibition of cell adhesion protein expression and NFκB activation in endothelial cells
Thomas Waldow et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2006)
Adoptive immunotherapy for cancer: building on success
L Gattinoni et al.
NATURE REVIEWS IMMUNOLOGY (2006)
DNA and adenoviral vectors encoding carcinoembryonic antigen fused to immunoenhancing sequences augment antigen-specific immune response and confer tumor protection
A Facciabene et al.
HUMAN GENE THERAPY (2006)
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma
ME Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo
JN Liu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Vascular leukocytes contribute to tumor vascularization
JR Conejo-Garcia et al.
BLOOD (2005)
Endothelin-1-, endothelin-A-, and endothelin-B-receptor expression is correlated with vascular endothelial growth factor expression and angiogenesis in breast cancer
P Wülfing et al.
CLINICAL CANCER RESEARCH (2004)
C5a-induced gene expression in human umbilical vein endothelial cells
EA Albrecht et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
The ability of two Listeria monocytogenes vaccines targeting human papillomavirus-16 E7 to induce an antitumor response correlates with myeloid dendritic cell function
XH Peng et al.
JOURNAL OF IMMUNOLOGY (2004)
Decay-accelerating factor induction on vascular endothelium by vascular endothelial growth factor (VEGF) is mediated via a VEGF receptor-2 (VEGF-R2)- and protein kinase C-α/ε (PKC α/ε)-dependent cytoprotective signaling pathway and is inhibited by cyclosporin A
JC Mason et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Decay-accelerating factor induction by tumour necrosis factor-α, through a phosphatidylinositol-3 kinase and protein kinase C-dependent pathway, protects murine vascular endothelial cells against complement deposition
SR Ahmad et al.
IMMUNOLOGY (2003)
Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells
T Monsinjon et al.
FASEB JOURNAL (2003)
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
L Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis
MM Mazanet et al.
JOURNAL OF IMMUNOLOGY (2002)
Differential expression of beta 1 and beta 2 integrins and L-selectin on CD4(+) and CD8(+) T lymphocytes in human blood: comparative analysis between isolated cells, whole blood samples and cryopreserved preparations
M Cavers et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16
GR Gunn et al.
JOURNAL OF IMMUNOLOGY (2001)
分享论文
